IoC2-Guided Remifentanil Titration for Early Postoperative Pain After Laparoscopic Cholecystectomy
Effect of IoC2-guided Remifentanil Titration on Early Postoperative Pain After Elective Laparoscopic Cholecystectomy: a Single-centre, Patient- and Assessor-blinded, Randomized Superiority Trial
This is a single-centre, patient- and outcome-assessor-blinded, active-controlled, randomized superiority trial. The study will test whether remifentanil titration guided by the Index of Consciousness 2 (IoC2) displayed on the Angel-6000 monitor reduces early postoperative pain during the first 60 minutes after post-anaesthesia care unit (PACU) arrival compared with standardized remifentanil titration with IoC2 concealed, in adults undergoing elective laparoscopic cholecystectomy for benign gallbladder disease.
研究概览
地位
条件
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Yi Duan
- 电话号码:86 13810385311
- 邮箱:dya01610@btch.edu.cn
学习地点
-
-
Beijing Municipality
-
Beijing、Beijing Municipality、中国、102218
- 招聘中
- Beijing Tsinghua Changgung Hospital
-
接触:
- Yi Duan, MD
- 电话号码:+86-13810385311
- 邮箱:dya01610@btch.edu.cn
-
接触:
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Age 18-75 years, of any sex
- American Society of Anesthesiologists (ASA) physical status I-III
- Elective standard three- or four-port laparoscopic cholecystectomy under general anaesthesia for benign gallbladder disease (gallstones, chronic cholecystitis, or gallbladder polyps)
- Planned total intravenous anaesthesia, with the surgeon expecting completion through a standard laparoscopic approach
- Ability to understand the 0-10 NRS and follow-up procedures and to complete assessments in Chinese
- Written informed consent
Exclusion Criteria:
- Emergency surgery; active acute cholecystitis, cholangitis, or acute pancreatitis; planned open, single-port, robotic, common-bile-duct exploration, or combined surgery; or expected postoperative mechanical ventilation
- Persistent preoperative moderate-to-severe pain (resting NRS ≥4) or daily opioid use for more than 7 days during the preceding 30 days
- Severe cognitive, psychiatric, language, hearing, or communication impairment that precludes reliable pain assessment
- Severe cardiac, pulmonary, hepatic, or renal dysfunction, or another condition that in the investigator's judgement precludes standardized anaesthesia
- Contraindication to propofol, remifentanil, rocuronium, acetaminophen, a non-steroidal anti-inflammatory drug, dexamethasone, local anaesthetic, or the planned rescue medication
- Pregnancy or breastfeeding
- Frontal skin injury, severe adhesive allergy, or another condition preventing electrode placement
- Participation within the previous 3 months in another interventional study that could affect the primary outcome
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Experimental group
IoC2-guided remifentanil titration |
IoC2 displayed on Angel-6000 monitor; target range 35-45; titration step 0.5 ng/mL effect-site concentration |
|
有源比较器:Control Group
Standardized titration with IoC2 concealed |
Standardized titration with IoC2 concealed |
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
NRS(0-10 numerical rating scale) score
大体时间:60 minutes
|
60 minutes
|
合作者和调查者
赞助
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 27031-0-02
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.